Market Access Sponsored Navigating Routes to Commercial Excellence in Cell and Gene ... 'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.
Debates & Insight Sponsored Pricing & Market Access Outlook 2015/2016 Edition Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need
Debates & Insight Sponsored Computer Gaming: The Future of Decision-Making for Life Scie... How can life science brands identify winning strategic decisions when there are so many variables to consider?
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends